Healthcare Pharmaceutical Biotech

Medical Care Technologies Inc. (OTC PINK:MDCE) Highlights Execution Momentum and Expanding AI Pipeline Following Strategic Growth Initiative

April 24, 2026 8:57 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) today provided an operational update highlighting continued execution momentum and the expansion of its artificial intelligence platform following its recently announced strategic capital initiative. As the Company transitions into a revenue-focused phase, management is prioritizing the scaling of its newly launched consumer application, Snapshot Recipes, while simultaneously advancing...

Read more

Jaguar Health Announces Acceptance of two Late-Breaking Abstracts for Liquid Oral Crofelemer Treatment of Intestinal Failure in Pediatric Patients at the European Society for Pediatric Gastroenterology, Hepatology & Nutrition (ESPGHAN)

April 24, 2026 8:30 AM

Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) family company Napo Pharmaceuticals (Napo) today announced the acceptance of two late breaking abstracts for the treatment of pediatric IF from MVID and SBS at the 58th Annual Meeting of ESPGHAN. These pediatric IF patients are receiving liquid oral crofelemer as an investigational drug under two separate investigator-initiated trials. One infant MVID IF patient is being treated with crofelemer as...

Read more

Senzime's TetraGraph System Contracted on Three Leading GPO Agreements in the US

April 24, 2026 7:50 AM

Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB today announced that the TetraGraph System has secured inclusion in agreements with Vizient, Premier, and HealthTrust Performance Group, the three leading US Group Purchasing Organizations (GPOs). Approximately 95% of US hospitals engage with GPOs to support procurement processes, and these listings have the potential to expand and accelerate Senzime's market reach. "Inclusion in all three major US...

Read more

Senzime Publishes Annual and Sustainability Report for 2025

April 24, 2026 6:20 AM

Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB (publ) announces today that the company's annual and sustainability report for 2025 is published and available on www.senzime.com "2025 was the year we increased the growth rate and exceeded SEK 100 million in sales. We achieved our communicated goals for sales growth in constant currencies and kept costs according to plan. We secured several major strategic wins, strengthened our leading market...

Read more

Advanced Marketing Systems Drive Measurable Growth for Leading Plastic Surgery Clinics

April 24, 2026 3:50 AM

A growing number of leading plastic surgery clinics across major U.S. markets are adopting advanced, data-driven marketing systems to improve patient acquisition, streamline operations, and increase conversion rates. While patient-facing experiences in high-performing clinics may appear unchanged, significant transformation is taking place behind the scenes. Clinics are shifting away from fragmented marketing tactics toward fully integrated...

Read more

AlzeCure Pharma Carries Out a Fully Secured Rights Issue of Approximately SEK 30.1 million

April 24, 2026 2:20 AM

AlzeCure Pharma AB (STO:ALZCUR)(FRA:AC6), a pharmaceutical company that develops small molecule drug candidates for CNS diseases, with a focus on Alzheimer's disease and pain, today announces that the Board of Directors, based on the authorization granted by the Annual General Meeting on 14 May 2025, has resolved on a new share issue of approximately SEK 30.1 million through the issuance of up to 22,982,891 shares at a subscription price of SEK...

Read more

Interim Report January - March 2026

April 24, 2026 1:50 AM

XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) First quarter 2026 (Jan-Mar) Net sales amounted to SEK 241.0 million (218.6), corresponding to growth of 10 percent in SEK. Organic growth was 23 percent in local currencies. Excluding revenue from heart trials the organic growth was 18 percent in local currencies. Thoracic sales increased by 27 percent in local currencies and by 19 percent excluding revenue from heart trials. Abdominal sales...

Read more

Evotec Announces Chief Financial Officer Transition

April 24, 2026 1:50 AM

Evotec SE (NASDAQ:EVO)(Frankfurt Prime Standard:EVT) today announced that Chief Financial Officer (CFO) Paul Hitchin will step down on April 30, 2026, for personal reasons unrelated to the company. The Supervisory Board has accepted Mr. Hitchin's decision and expressed deep appreciation for his leadership and significant contributions to the company. Since March 1, 2025, he successfully led Evotec through a significant financial and strategic...

Read more

Psyence Group Inc. Announces Amendment to Amalgamation Agreement with GoldCoast Resource Corp.

April 23, 2026 6:30 PM

Psyence Group Inc. (CSE:PSYG) ("Psyence" or the "Company") is pleased to announce that it has entered into an amendment dated April 13, 2026 (the "Amendment") to the previously announced amalgamation agreement dated November 21, 2025, as amended (the "Amalgamation Agreement"), among Psyence, Psyence Therapeutics Corp. ("Psyence Subco") and GoldCoast Resource Corp. ("GoldCoast"), in connection with the proposed amalgamation transaction previously...

Read more

Medicure Reports Financial Results for the Year Ended December 31, 2025 and Schedules April 27, 2026 Conference Call

April 23, 2026 6:15 PM

Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today reported its results from operations for the year ended December 31, 2025 and will have a conference call to present the Financial Results on April 27, 2026 at 8:30 am Eastern Time. Quarter and Year Ended December...

Read more

Onco-Innovations Advances Polymer Testing as It Moves Its PNKP Inhibitor Technology Toward IND-Enabling Studies

April 23, 2026 6:00 PM

Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that it has advanced an analytical method used to measure and control a key polymer within its PNKP Inhibitor Technology (the "Technology"), supporting continued formulation development and scale-up as the Company advances toward its goal of clinical manufacturing. This work is intended to help ensure consistency in...

Read more

Hillsboro Health Recognized Among Nation's Top Rural Hospitals

April 23, 2026 5:05 PM

Hillsboro Health has been ranked one of the Top 20 Critical Access Hospitals in the nation for Best Practices in Patient Satisfaction by the National Rural Health Association. The recognition highlights Hillsboro Health's commitment to providing care that patients trust, value and recommend. The award places Hillsboro Health among the nation's top rural hospitals for patient satisfaction. "This recognition shows the dedication of our team...

Read more

BUDZ Highlights Valuable Legacy Genetics Portfolio Following Historic Federal Schedule III Marijuana Action WEED Inc. (OTCQB:BUDZ) Positioned with Rare Landrace Strains as DOJ Announces Immediate Schedule III Pathway for Qualified Medical Marijuana Products

April 23, 2026 4:35 PM

WEED Inc. (OTCQB:BUDZ) ("BUDZ" or the "Company"), a cannabis bioresearch and genetics-focused public company, today issued a strategic corporate update following the U.S. Department of Justice and Drug Enforcement Administration announcement placing FDA-approved marijuana products and marijuana products subject to qualifying state-issued medical licenses into Schedule III of the Controlled Substances Act, while beginning an expedited hearing...

Read more

Trump Marijuana Schedule III Is Not Deregulation - It Activates U.S. Treaty Obligations and Federal Cannabis Quotas

April 23, 2026 3:50 PM

The recent decision by the U.S. Attorney General and the Drug Enforcement Administration to move certain forms of medical marijuana into Schedule III marks the beginning-not the end-of federal cannabis regulation. While many operators are celebrating anticipated tax relief under Section 280E, few are recognizing what the rescheduling order actually triggers: International treaty compliance, federal quota control, and DEA oversight of the...

Read more

TailorMed Expands its Solutions Suite to Address Barriers Across the Medication Journey, Building on its Market-Leading Affordability Solution and Growing its National Network

April 23, 2026 10:00 AM

TailorMed, the medication success platform removing barriers across the patient journey, today announced a new chapter in its growth, extending its affordability solutions to tackle additional barriers across access and adherence. While affordability remains a core challenge, patients often encounter multiple barriers that prevent them from starting and staying on therapy, from delays at the point of prescription to lack of ongoing support after...

Read more

Zen Hut Launches Refined London Wellness Model Centered on Fair Therapist Pay

April 23, 2026 9:35 AM

Zen Hut, the at home wellness app developed by the team behind The Massage People, today announced the launch of its refined London service model following several years of testing, iteration, and brand development. The wider business first entered the market more than 10 years ago through The Massage People, building operational experience in mobile massage, therapist recruitment, customer support, and booking technology. In 2023, the company...

Read more

Medical Care Technologies Inc. (OTC PINK:MDCE) Accelerates Growth Strategy with Strategic Capital Raise Following Launch of AI Consumer Platform

April 23, 2026 9:17 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) today announced a strategic capital raise designed to accelerate the Company's rapid transition into a revenue-generating artificial intelligence platform company. This initiative follows the successful launch of Snapshot Recipes, the Company's first consumer-facing AI mobile application-marking a major milestone as Medical Care Technologies evolves from development into active commercialization....

Read more

Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2026

April 23, 2026 9:00 AM

In the first calendar quarter (1Q) of 2026, Utah Medical Products, Inc. (Nasdaq:UTMD) attained financial results which were consistent with its previously announced projections for calendar year 2026. But because of the relatively short span of time, results for any given three-month period in comparison with a previous three-month period may not be indicative of comparative results for the year as a whole. Summary of results. The following is a...

Read more

Aetna Better Health(R) of Virginia Opens New Community Resource Center in Roanoke

April 23, 2026 9:00 AM

Originally published on CVS Health Company News Aetna Better Health® of Virginia, a CVS Health® company (NYSE:CVS), announced the opening of its new Community Resource Center (CRC) in Roanoke, located at the Roanoke Redevelopment and Housing Authority's EnVision Center. The CRC is open to the public and expands access to health and wellness services by helping individuals and families navigate health care benefits, connect to local resources and...

Read more

Nation's Top Medical Equipment Rental Provider Expands to Portland as Oregon Hospitals Confront Nation's Second-Tightest Bed Supply

April 23, 2026 9:00 AM

US Med-Equip, recognized as the nation's "best" medical equipment rental provider, opened a Portland branch to deliver life-saving equipment at a moment's notice to hospitals across Oregon and Southwest Washington as the region prepares for one of its largest inpatient capacity expansions in decades. Oregon's growing 65-and-older population is projected to outnumber residents under 18 within the next several years, driving demand for critical...

Read more